$20.700
-0.733 (-3.54%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
该买入 Attovia Therapeutics Inc 股票吗？
Attovia Therapeutics, Inc. is a good buy right now due to its recent successful IPO that raised approximately $289 million, reflecting strong market interest. The stock is currently priced at $20.70, which is significantly lower than the analyst price target of $25, suggesting a potential upside of about 20.5%. Additionally, the forward P/E ratio of 4.81 indicates that the stock may be undervalued compared to future earnings expectations. However, the main risk is the negative net income reported for Q1 2026, which stands at -18.66 million USD, indicating ongoing financial challenges.
ATTO 股价于 Friday 收于 $20.70，此前下跌 -3.54%
Attovia Therapeutics Inc (ATTO) last closed at $20.7, losing -3.54%. These facts feed the 1-day and 1-week ATTO price prediction above.
预测驱动因素
Attovia Therapeutics Inc（ATTO）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Seasonality
Bullish
ATTO 季节性分析
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。